CHD

Church & Dwight

$101.30

-0.02%
Aug 14, 2026
Bobby Quantitative Model
Church & Dwight Co., Inc. is a leading consumer packaged goods company, best known as the world's largest producer of baking soda, with a diversified portfolio spanning laundry, cat litter, oral care, deodorant, and nasal care products under iconic brands like Arm & Hammer, OxiClean, and Batiste. The company holds a strong market position in the household and personal products industry, leveraging its brand equity and innovation to compete with larger rivals like Procter & Gamble and Colgate-Palmolive. Currently, the investor narrative centers on the company's ability to sustain growth through strategic acquisitions (e.g., Touchland hand sanitizer) and brand expansion, while navigating input cost pressures and a competitive retail environment. Recent quarterly results show modest revenue growth, prompting debates about whether the company can accelerate organic growth and expand margins in a mature category.

People also watch

Procter & Gamble

Procter & Gamble

PG

Analysis
Colgate-Palmolive Company

Colgate-Palmolive Company

CL

Analysis
Kenvue

Kenvue

KVUE

Analysis
Kimberly-Clark

Kimberly-Clark

KMB

Analysis
Estée Lauder Companies

Estée Lauder Companies

EL

Analysis

CHD 12-Month Price Forecast

Historical Price
Current Price $101.30
Average Target $101.30
High Target $116.49
Low Target $86.10

Wall Street consensus

Most Wall Street analysts maintain a constructive view on Church & Dwight's 12-month outlook, with a consensus price target around $105.37 and implied upside of +4.0% versus the current price.

Average Target

$105.37

0 analysts

Implied Upside

+4.0%

vs. current price

Analyst Count

covering this stock

Price Range

$78 - $115

Analyst target range

The target price range spans from a low of $78.00 to a high of $115.00, representing a wide spread of 47% from low to high, which signals considerable uncertainty about the stock's future performance. The high target of $115 assumes continued market share gains and successful integration of recent acquisitions, while the low target of $78 likely prices in margin compression and competitive pressures. Recent ratings actions have been mostly neutral, with Wells Fargo reiterating Overweight and RBC Capital maintaining Outperform, but Barclays remains Underweight, reflecting a split in the analyst community.

Drowning in data?

Find the real signal!

CHD Technical Analysis

The stock is in a clear uptrend over the past year, with a 1-year price change of +11.74%, though it has underperformed the S&P 500's +21.46% gain over the same period. Currently trading at $103.36, the stock sits near the top of its 52-week range of $81.33 to $106.04, at approximately 97.5% of the range. This positioning near the highs indicates strong momentum, but also suggests the stock may be overextended in the short term, especially given the recent sharp run-up from the May lows.

Beta

0.47

0.47x market volatility

Max Drawdown

-17.6%

Largest decline past year

52-Week Range

$81-$106

Price range past year

Annual Return

+9.4%

Cumulative gain past year

PeriodCHD ReturnS&P 500
1m+4.3%+2.9%
3m+7.7%+5.0%
6m-0.1%+13.9%
1y+9.4%+20.4%
ytd+22.6%+13.8%

Bobby - Your AI Investment Partner

Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions

CHD Fundamental Analysis

Revenue growth has been sluggish, with the most recent quarter (Q1 2026) showing revenue of $1.469 billion, up only 0.15% year-over-year. This marks a deceleration from the prior year's Q1 growth of 0.15% (essentially flat), and the multi-quarter trend shows revenue fluctuating between $1.47 billion and $1.64 billion, indicating stagnation. The company's growth is being driven primarily by its specialty products and international segments, but the core consumer domestic business is mature, limiting overall expansion.

Quarterly Revenue

$1.5B

2026-03

Revenue YoY Growth

+0.1%

YoY Comparison

Gross Margin

46.4%

Latest Quarter

Free Cash Flow

$1.1B

Last 12 Months

Revenue & Net Income Trends (2 Years)

Revenue Breakdown

Specialty Products Division

Open an Account, get $2 TSLA now!

Valuation Analysis: Is CHD Overvalued?

Given that Church & Dwight is profitable with a trailing net income of $216.3 million in Q1 2026, the most appropriate valuation metric is the price-to-earnings (PE) ratio. The trailing PE is 27.58x, while the forward PE is 25.58x, implying the market expects earnings growth of approximately 7.8% over the next year. The gap between trailing and forward PE suggests modest growth expectations, which is consistent with the company's low single-digit revenue growth and margin expansion initiatives.

PE

27.6x

Latest Quarter

vs. Historical

Low-End

5-Year PE Range 22x~39x

vs. Industry Avg

N/A

Industry PE ~N/A*

EV/EBITDA

17.0x

Enterprise Value Multiple